Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 796 AL 810

Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease

Cavedo E, Dubois B, Colliot O, Lista S, Croisile B, Tisserand GL, Touchon J, Bonafe A, Ousset PJ, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Galluzzi S, Delmaire C, Ceccaldi M, Girard N, Lehericy S, Duveau F, Chupin M, Sarazin M, Dormont D, Hampel H; Hippocampus Study Group.

J Clin Psychiatry. 2016 Dec;77(12):e1631-e1638. doi: 10.4088/JCP.15m10413.

Cognitive Outcomes of Cardiovascular Surgical Procedures in the Old: An Important but Neglected Area

Keage HA, Smith A, Loetscher T, Psaltis P.

Heart Lung Circ. 2016 Dec;25(12):1148-1153. doi: 10.1016/j.hlc.2016.09.002. Epub 2016 Sep 23.

Calcium-Channel Blockers and Dementia Risk in Older Adults - National Health Insurance Service - Senior Cohort (2002-2013)

Hwang D, Kim S, Choi H, Oh IH, Kim BS, Choi HR, Kim SY, Won CW.

Circ J. 2016 Oct 25;80(11):2336-2342. doi: 10.1253/circj.CJ-16-0692. Epub 2016 Sep 21.

Dietary arachidonic acid as a risk factor for age-associated neurodegenerative diseases: Potential mechanisms

Thomas MH, Pelleieux S, Vitale N, Olivier JL.

Biochimie. 2016 Nov;130:168-177. doi: 10.1016/j.biochi.2016.07.013. Epub 2016 Jul 26.

Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study

Boccardi M, Altomare D, Ferrari C, Festari C, Guerra UP, Paghera B, Pizzocaro C, Lussignoli G, Geroldi C, Zanetti O, Cotelli MS, Turla M, Borroni B, Rozzini L, Mirabile D, Defanti C, Gennuso M, Prelle A, Gentile S, Morandi A, Vollaro S, Volta GD, Bianchetti A, Conti MZ, Cappuccio M, Carbone P, Bellandi D, Abruzzi L, Bettoni L, Villani D, Raimondi MC, Lanari A, Ciccone A, Facchi E, Di Fazio I, Rozzini R, Boffelli S, Manzoni L, Salvi GP, Cavaliere S, Belotti G, Avanzi S, Pasqualetti P, Muscio C, Padovani A, Frisoni GB; Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Working Group.

JAMA Neurol. 2016 Dec 1;73(12):1417-1424. doi: 10.1001/jamaneurol.2016.3751.

Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial

Realdon O, Rossetto F, Nalin M, Baroni I, Cabinio M, Fioravanti R, Saibene FL, Alberoni M, Mantovani F, Romano M, Nemni R, Baglio F.

BMC Psychiatry. 2016 Nov 25;16(1):425. doi: 10.1186/s12888-016-1132-y.

Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study

Tolppanen AM, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S.

BMC Geriatr. 2016 Dec 1;16(1):204. doi: 10.1186/s12877-016-0383-2.

The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease

Grizzanti J, Lee HG, Camins A, Pallas M, Casadesus G.

Nutr Res. 2016 Dec;36(12):1305-1315. doi: 10.1016/j.nutres.2016.11.002. Epub 2016 Nov 8.

Editorial (Thematic Issue: Endocrine Disorders and Cognitive Function in the Elderly)

Pasqualetti G, Calsolaro V, Monzani F.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):2-3. doi: 10.2174/187221481001161005181628.

Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease

Kwakowsky A, Milne MR, Waldvogel HJ, Faull RL.

Int J Mol Sci. 2016 Dec 17;17(12):2122. doi: 10.3390/ijms17122122.

Structured Outlier Detection in Neuroimaging Studies with Minimal Convex Polytopes

Varol E, Sotiras A, Davatzikos C.

Med Image Comput Comput Assist Interv. 2016 Oct;9900:300-307. doi: 10.1007/978-3-319-46720-7_35. Epub 2016 Oct 2.

The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up

Wallin A, Nordlund A, Jonsson M, Lind K, Edman Å, Göthlin M, Stålhammar J, Eckerström M, Kern S, Börjesson-Hanson A, Carlsson M, Olsson E, Zetterberg H, Blennow K, Svensson J, Öhrfelt A, Bjerke M, Rolstad S, Eckerström C.

J Cereb Blood Flow Metab. 2016 Jan;36(1):114-31. doi: 10.1038/jcbfm.2015.147.

Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

Wallin A, Nordlund A, Jonsson M, Blennow K, Zetterberg H, Öhrfelt A, Stålhammar J, Eckerström M, Carlsson M, Olsson E, Göthlin M, Svensson J, Rolstad S, Eckerström C, Bjerke M.

J Cereb Blood Flow Metab. 2016 Jan;36(1):95-113. doi: 10.1038/jcbfm.2015.148.

Neurophysiological assessment of Alzheimer's disease individuals by a single electroencephalographic marker

Lizio R, Del Percio C, Marzano N, Soricelli A, Yener GG, Başar E, Mundi C, De Rosa S, Triggiani AI, Ferri R, Arnaldi D, Nobili FM, Cordone S, Lopez S, Carducci F, Santi G, Gesualdo L, Rossini PM, Cavedo E, Mauri M, Frisoni GB, Babiloni C.

J Alzheimers Dis. 2016;49(1):159-77. doi: 10.3233/JAD-143042.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias